Remember, the only thing scarier than findings is no findings. Go break some eggs.

Your Weekly Briefing:

👀 Insights

The 5 Questions That Decide Adversity

Every tox finding gets the same interrogation: dose response, reversibility, histopath correlation, biological significance, consistency across sex and species. In 10 minutes, I walk through the flowchart sponsors, study directors, and pathologists actually use to call a finding adverse — and what each answer means for your NOAEL.

💭 Myths v. Realities

Myth: Adverse effects are show stoppers that need to be avoided at all costs.

Reality: Adverse effects actually anchor your NOAEL, give you a foundation for your human starting dose, and provide usable threshold for toxicity in relation to the clinic. They are as meaningful to your tox study as TK is.

🔧 Tools

A checklist to help determine if a finding is adverse or not, and what to do next

Adverse Finding Checklist

A practical companion to this week's video. The same 5 questions, expanded into a working reference — what to look for, what good documentation reads like, and the red flags FDA scrutinizes.

The Adverse Finding Checklist.pdf

The Adverse Finding Checklist.pdf

118.18 KBPDF File

Want more of this? 👇

THE NONCLINICAL | Drug development made simple.

Recommended for you